Pharmacotherapy for Treatment-Resistant Depression Antidepressants and Atypical Antipsychotics

被引：14
作者：
Vas, Collin [1 ]
Jain, Ayush [2 ]
Trivedi, Mili [3 ]
Jha, Manish Kumar [4 ]
Mathew, Sanjay J. [5 ]
机构：
[1] UT Southwestern Med Ctr, Dallas, TX USA
[2] Shri Ram Sch, Gurgaon, Haryana, India
[3] Colleyville Heritage High Sch, Colleyville, TX USA
[4] UT Southwestern Med Ctr, Ctr Depress Res & Clin Care, 5323 Harry Hines Blvd, Dallas, TX 75390 USA
[5] Baylor Coll Med, Michael E DeBakey VA Med Ctr, Menninger Dept Psychiat & Behav Sci, Menninger Clin, Houston, TX USA
来源：
PSYCHIATRIC CLINICS OF NORTH AMERICA | 2023年 / 46卷 / 02期
关键词：
Major depressive disorder; Antidepressants; Treatment-resistant depression; Atypical antipsychotics; Aripiprazole; Brexpiprazole; Cariprazine; Quetiapine; EXTENDED-RELEASE QUETIAPINE; STAR-ASTERISK-D; DOUBLE-BLIND; INADEQUATE-RESPONSE; OLANZAPINE/FLUOXETINE COMBINATION; ADJUNCTIVE THERAPY; ARIPIPRAZOLE AUGMENTATION; OUTPATIENTS FINDINGS; DISORDER; EFFICACY;
D O I：
10.1016/j.psc.2023.02.012
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
Major depressive disorder (MDD) is an often chronic and/or recurrent disorder that is associated with dysfunctions in multiple aspects of life including work and non-work related productivity, psychosocial function, and quality of life.1-5It is widely prevalent and is estimated to affect one in five adults in the United States during their lifetime.6 Although universal screening and use of measurement-based care can assist with
引用
收藏
页码：261 / 275
页数：15
相关论文
共 80 条
[1]  
AbbVie. U.S. FDA, 2022, APPR VRAYLAR CAR ADJ
[2]   A randomised, placebo-controlled 24-week study evaluating adjunctive brexpiprazole in patients with major depressive disorder [J].
Bauer, Michael ;
Hefting, Nanco ;
Lindsten, Annika ;
Josiassen, Mette Krog ;
Hobart, Mary .
ACTA NEUROPSYCHIATRICA, 2019, 31 (01) :27-35
[3]   A pooled analysis of two randomised, placebo-controlled studies of extended release quetiapine fumarate adjunctive to antidepressant therapy in patients with major depressive disorder [J].
Bauer, Michael ;
El-Khalili, Nizar ;
Datto, Catherine ;
Szamosi, Johan ;
Eriksson, Hans .
JOURNAL OF AFFECTIVE DISORDERS, 2010, 127 (1-3) :19-30
[4]   Extended-Release Quetiapine as Adjunct to an Antidepressant in Patients With Major Depressive Disorder: Results of a Randomized, Placebo-Controlled, Double-Blind Study [J].
Bauer, Michael ;
Pretorius, Herman W. ;
Constant, Eric L. ;
Earley, Willie R. ;
Szamosi, Johan ;
Brecher, Martin .
JOURNAL OF CLINICAL PSYCHIATRY, 2009, 70 (04) :540-549
[5]   A double-blind, placebo-controlled study of citalopram with and without lithium in the treatment of therapy-resistant depressive patients: A clinical, pharmacokinetic, and pharmacogenetic investigation [J].
Baumann, P ;
Nil, R ;
Souche, A ;
Montaldi, S ;
Baettig, D ;
Lambert, S ;
Uehlinger, C ;
Kasas, A ;
Amey, M ;
JonzierPerey, M .
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 1996, 16 (04) :307-314
[6]   The efficacy and safety of aripiprazole as adjunctive therapy in major depressive disorder: A multicenter, randomized, double-blind, placebo-controlled study [J].
Berman, Robert M. ;
Marcus, Ronald N. ;
Swanink, Rene ;
McQuade, Robert D. ;
Carson, William H. ;
Corey-Lisle, Patricia K. ;
Khan, Arif .
JOURNAL OF CLINICAL PSYCHIATRY, 2007, 68 (06) :843-853
[7]   Aripiprazole Augmentation in Major Depressive Disorder: A Double-Blind, Placebo-Controlled Study in Patients with Inadequate Response to Antidepressants [J].
Berman, Robert M. ;
Fava, Maurizio ;
Thase, Michael E. ;
Trivedi, Madhukar H. ;
Swanink, Rene ;
McQuade, Robert D. ;
Carson, William H. ;
Adson, David ;
Taylor, Leslie ;
Hazel, James ;
Marcus, Ronald N. .
CNS SPECTRUMS, 2009, 14 (04) :197-206
[8]   Efficacy and Safety of Olanzapine/Fluoxetine Combination vs Fluoxetine Monotherapy Following Successful Combination Therapy of Treatment-Resistant Major Depressive Disorder [J].
Brunner, Elizabeth ;
Tohen, Mauricio ;
Osuntokun, Olawale ;
Landry, John ;
Thase, Michael E. .
NEUROPSYCHOPHARMACOLOGY, 2014, 39 (11) :2549-2559
[9]   Tardive dyskinesia risk with first- and second-generation antipsychotics in comparative randomized controlled trials: a meta-analysis [J].
Carbon, Maren ;
Kane, John M. ;
Leucht, Stefan ;
Correll, Christoph U. .
WORLD PSYCHIATRY, 2018, 17 (03) :330-340
[10]   Neuromodulation Strategies for the Treatment of Depression [J].
Conroy, Susan K. ;
Holtzheimer, Paul E. .
AMERICAN JOURNAL OF PSYCHIATRY, 2021, 178 (12) :1082-1088
12345678